Pfizer Inc. et al v. Apotex, Inc. et al
| Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company and Pfizer Inc. |
| Apotex, Inc. and Apotex Corp. |
| Apotex, Inc. and Apotex Corp. |
| Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company and Pfizer Inc. |
| 1:2024cv00621 |
| May 23, 2024 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 8, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 20
ORDER: on or before August 9, 2024, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/ or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER Setting Deadlines: ( Notice of Compliance deadline set for 8/9/2024.) Signed by Judge Colm F. Connolly on 7/8/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf)
|
| Filing 19 Pro Hac Vice Fee - Credit Card Payment received for Joseph M. Janusz. ( re #18 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz )( Payment of $ 50, receipt number ADEDC-4445708).(Hitch, Cortlan) |
| Filing 18 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz - filed by Apotex Corp., Apotex, Inc.. (Hitch, Cortlan) |
|
SO ORDERED, re #18 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz filed by Apotex, Inc., Apotex Corp. Signed by Judge Colm F. Connolly on 7/8/2024. (nmf)
|
| Pro Hac Vice Attorney Jillian M. Schurr, Lance A. Soderstrom for Apotex Corp. and Apotex, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Filing 17 Pro Hac Vice Fee - Credit Card Payment received for Deepro R. Mukerjee, Christopher B. Prescott, Jillian M. Schurr, and Lance A. Soderstrom. ( re #16 MOTION for Pro Hac Vice Appearance of Attorney Deepro R. Mukerjee, Attorney Christopher B. Prescott, Attorney Jillian M. Schurr and Attorney Lance A. Soderstrom )( Payment of $ 200, receipt number ADEDC-4444046).(Dorsney, Kenneth) |
| Filing 16 MOTION for Pro Hac Vice Appearance of Attorney Deepro R. Mukerjee, Attorney Christopher B. Prescott, Attorney Jillian M. Schurr and Attorney Lance A. Soderstrom - filed by Apotex Corp., Apotex, Inc.. (Dorsney, Kenneth) |
|
SO ORDERED, re #16 MOTION for Pro Hac Vice Appearance of Attorney Deepro R. Mukerjee, Attorney Christopher B. Prescott, Attorney Jillian M. Schurr and Attorney Lance A. Soderstrom filed by Apotex, Inc., Apotex Corp. Signed by Judge Colm F. Connolly on 7/3/2024. (nmf)
|
| Filing 15 NOTICE OF SERVICE of Apotex's ANDA Production filed by Apotex Corp., Apotex, Inc..(Dorsney, Kenneth) |
| Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdco Inc. for Apotex, Inc.; Corporate Parent Aposherm Delaware Holdings Corp. for Apotex Corp. filed by Apotex Corp., Apotex, Inc.. (Dorsney, Kenneth) |
| Filing 13 ANSWER to #1 Complaint, , COUNTERCLAIM against All Plaintiffs by Apotex, Inc., Apotex Corp..(Dorsney, Kenneth) |
| Filing 12 SUMMONS Returned Executed by Pfizer Inc., Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceutials.Apotex, Inc. served on 6/13/2024, answer due 7/5/2024. (Dellinger, Megan) |
| Filing 11 SUMMONS Returned Executed by Pfizer Inc., Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceutials.Apotex Corp. served on 6/13/2024, answer due 7/5/2024. (Dellinger, Megan) |
| Pro Hac Vice Attorney John P. Scheibeler for Bristol-Myers Squibb Company,Pfizer Inc. and for Pfizer Ireland Pharmaceutials added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney Dimitrios T. Drivas for Bristol-Myers Squibb Company, Pfizer Inc., and Pfizer Ireland Pharmaceutials added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney Joel L. Broussard for Bristol-Myers Squibb Company, Pfizer Inc., and Pfizer Ireland Pharmaceutials added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Filing 10 Pro Hac Vice Fee - Credit Card Payment received for Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard. ( re #9 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard )( Payment of $ 150, receipt number ADEDC-4419008).(Dellinger, Megan) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard - filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceutials. (Dellinger, Megan) |
|
SO ORDERED, re (8 in 1:24-cv-00626-CFC, 8 in 1:24-cv-00627-CFC, 10 in 1:24-cv-00625-CFC, 11 in 1:24-cv-00622-CFC, 9 in 1:24-cv-00623-CFC, 10 in 1:24-cv-00624-CFC, 9 in 1:24-cv-00621-CFC) MOTION for Pro Hac Vice Appearance of Attorneys Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard, filed by Pfizer Inc., Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceuticals. Ordered by Judge Colm F. Connolly on 5/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(kmd)
|
| Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:24-cv-00621-CFC et al.(nmf) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-00621-CFC through 1:24-cv-00627-CFC (rjb) |
| Filing 7 Summons Issued as to Apotex Corp. on 5/23/2024; Apotex, Inc. on 5/23/2024. (Attachments: #1 Summons Issued)(mrr) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Pfizer Ireland Pharmaceutials filed by Pfizer Inc., Pfizer Ireland Pharmaceutials. (mrr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company. (mrr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,314,117 B2; 8,759,372 B2; 11,083,724 B2. (mrr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 04/19/2024. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 8/27/2027. (mrr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Apotex Corp., Apotex, Inc. (Filing fee $ 405, receipt number ADEDC-4414645.) - filed by Pfizer Inc., Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceutials. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(mrr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
